BBH logo

VanEck Vectors Biotech ETF (BBH)

$205.55

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BBH

AUM

$400098989

P/E ratio

22.7

Dividend yield

0.4707%

Expense ratio

0.35%

Beta

0.685728

Price on BBH

Previous close

$210.13

Today's open

$206.39

Day's range

$205.17 - $206.39

52 week range

$154.75 - $212.54

Profile about BBH

show more

Headquarters

US

Exchange

NASDAQ Global Market

Issue type

Exchange-Traded Fund

BBH industries and sectors

Industries

Health

News on BBH

Which is the Better Choice for Healthcare Investors? IYH or BBH?

iShares U.S. Healthcare ETF provides broader exposure with 100 holdings compared to the 25 found in VanEck Biotech ETF VanEck Biotech ETF has delivered higher recent total returns but carries significantly greater historical price volatility iShares U.S. Healthcare ETF offers a higher dividend yield and lower five-year maximum drawdown for income-focused investors

news source

The Motley Fool • Jul 11, 2026

news preview

BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?

State Street SPDR S&P Pharmaceuticals ETF provides exposure to 65 companies compared to the 25 holdings in VanEck Biotech ETF. VanEck Biotech ETF has experienced a deeper maximum drawdown of almost 40% over the last five years.

news source

The Motley Fool • Jul 8, 2026

news preview

FHLC vs. BBH: Which Healthcare ETF Is the Better Buy?

Fidelity MSCI Health Care Index ETF (FHLC) provides broad sector exposure with significantly lower fees than VanEck Biotech ETF (BBH). BBH focuses on just 25 holdings in the biotech space while FHLC holds more than 300 positions across the entire healthcare industry.

news source

The Motley Fool • Jul 4, 2026

news preview

Investors Are Rotating Into Healthcare. Here's Why.

Janus Henderson portfolio manager Dan Lyons discusses why he sees opportunities for market outperformance in the healthcare sector as innovations in biotechnology, pharmaceuticals and medical devices proliferate. Check out our daily newsletter!

news source

Investors Business Daily • Jul 2, 2026

news preview

BIO CEO says more consistency needed in FDA review process

U.S. biotechnology industry trade group BIO worked with the Food and Drug ​Administration on plans announced on Monday to speed ‌clinical trials and expects the next initiative will aim to standardize the agency's review of drug applications, CEO John Crowley ​said on Tuesday.

news source

Reuters • Jun 23, 2026

news preview

Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A

The biotechnology sector has broken out of its multiyear bear market. As macroeconomic headwinds moderate and regulatory environments stabilize, biotech ETFs are surging.

news source

ETF Trends • Jun 23, 2026

news preview

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.

news source

Zacks Investment Research • Jun 10, 2026

news preview

Should You Invest in the VanEck Biotech ETF (BBH)?

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on December 20, 2011.

news source

Zacks Investment Research • May 11, 2026

news preview

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

news source

Seeking Alpha • May 2, 2026

news preview

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.

news source

Seeking Alpha • Apr 12, 2026

news preview

¹ Disclosures

Get started with M1

Invest in VanEck Vectors Biotech ETF

Open an M1 investment account to buy and sell VanEck Vectors Biotech ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BBH on M1